GLAXOSMITHKLINE PHARMACEUTICALS
Back to Balance Sheet
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Total Current Assets History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Current Assets | ₹2,494 Cr | ₹3,708 Cr | ₹2,023 Cr | ₹1,775 Cr | ₹3,356 Cr |
What is the latest Total Current Assets ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
Year | Total Current Assets |
---|---|
Mar2023 | ₹2,494 Cr |
Mar2022 | ₹3,708 Cr |
Mar2021 | ₹2,023 Cr |
Mar2020 | ₹1,775 Cr |
Mar2019 | ₹3,356 Cr |
How is Total Current Assets of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
Years | Total Current Assets | % Change | |
---|---|---|---|
Mar2023 | ₹2,494 Cr | -32.73 | |
Mar2022 | ₹3,708 Cr | 83.33 | |
Mar2021 | ₹2,023 Cr | 13.96 | |
Mar2020 | ₹1,775 Cr | -47.11 | |
Mar2019 | ₹3,356 Cr | - |
Compare Total Current Assets of peers of GLAXOSMITHKLINE PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLAXOSMITHKLINE PHARMACEUTICALS | ₹41,918.0 Cr | 8% | 27.4% | 84.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹358,689.0 Cr | -2.4% | 0.8% | 66.3% | Stock Analytics | |
CIPLA | ₹120,200.0 Cr | 6.4% | 10.5% | 61.7% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹109,222.0 Cr | 3.2% | 13.1% | 117.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹109,124.0 Cr | 5.1% | 9% | 31.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹98,293.5 Cr | 1.6% | -1% | 33.8% | Stock Analytics |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLAXOSMITHKLINE PHARMACEUTICALS | 8% |
27.4% |
84.5% |
SENSEX | 2.4% |
2.4% |
22.8% |
You may also like the below Video Courses